| 产品名称： | Burkholderia pyrrocinia (Imanaka et al.) Vandamme et al. |
|---|---|
| 商品货号： | TS209813 |
| Deposited As： | Pseudomonas pyrrocinia Imanaka et al. |
| Strain Designations： | 2327 CFBP 4794, CIP 105874, DSM 10685, LMG 14191 |
| Application： | Produces pyrrolnitrin |
| Isolation： | Soil Isolation date: April, 1963 |
| Biosafety Level： | 1
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Product Format： | freeze-dried |
| Storage Conditions： | 2°C to 8°C |
| Disclosure： | This material is cited in a US or other Patent and may not be used to infringe the claims. Depending on the wishes of the Depositor, ATCC may be required to inform the Patent Depositor of the party to which the material was furnished. This material may not have been produced or characterized by ATCC. |
| Preceptrol®： | no |
| Type Strain： | yes
Ref  Imanaka H, et al. . J. Antibiot. Ser. A 18: 205-206, 1965. , RefSkerman VB, et al. Approved lists of bacterial names. Int J Syst Bacteriol 30: 225-420, 1980. , RefVandamme P, et al. Occurrence of multiple genomovars of Burkholderia cepacia in cystic fibrosis patients and proposal of Burkholderia multivorans sp. nov.. Int. J. Syst. Bacteriol. 47: 1188-1200, 1997. PubMed: 9336927 |
| Medium： | ATCC® Medium 3: Nutrient agar or nutrient broth |
| Growth Conditions： | Temperature: 30.0°C Atmosphere: Aerobic |
| Name of Depositor： | Fujisawa Pharmaceutical Company, Ltd., H Imanaka |
| U.S. Patent Number： | |
| Special Collection： | ATCC |
| Year of Origin： | 1963 |
| References： | Arima K, et al. Production of 3-(2-nitro-3-chlorophenyl)-4-chloro-pyrrole. US Patent 3,597,325 dated Aug 3 1971 Arima K, et al. Antibiotic. US Patent 3,699,121 dated Oct 17 1972 Imanaka H, et al. . J. Antibiot. Ser. A 18: 205-206, 1965. Nishida M, et al. Pyrrolnitrin, a new antifungal antibiotic. Microbiological and toxicological observations. J. Antibiot. Ser. A 18: 211-219, 1965. Skerman VB, et al. Approved lists of bacterial names. Int J Syst Bacteriol 30: 225-420, 1980. Vandamme P, et al. Occurrence of multiple genomovars of Burkholderia cepacia in cystic fibrosis patients and proposal of Burkholderia multivorans sp. nov.. Int. J. Syst. Bacteriol. 47: 1188-1200, 1997. PubMed: 9336927 Imanaka H, et al. . J. Antibiot. Ser. A 18: 205-206, 1965. Skerman VB, et al. Approved lists of bacterial names. Int J Syst Bacteriol 30: 225-420, 1980. Vandamme P, et al. Occurrence of multiple genomovars of Burkholderia cepacia in cystic fibrosis patients and proposal of Burkholderia multivorans sp. nov.. Int. J. Syst. Bacteriol. 47: 1188-1200, 1997. PubMed: 9336927 |
| Cross References： | Nucleotide (GenBank) : M60743 P. pyorocivia chloroperoxidase gene, complete cds. Nucleotide (GenBank) : AB021369 Burkholderia pyrrocinia DNA for 16S rRNA, strain TS209813T. |
产品中心 Product Center
联系我们CONTACT US
-
0574-87917803
24小时服务热线 -
testobio@163.com
销售邮箱 -
浙江省宁波市高新区晶辉路866弄33号智造港E4幢3楼
地址
联系方式
-
章丽敏
17757489010 -
朱静
18067106081 -
李晴
18067408036 -
李晶晶
13375187189 -
周雪
13372109301
| 产品名称： | Burkholderia pyrrocinia (Imanaka et al.) Vandamme et al. |
|---|---|
| 商品货号： | TS209813 |
| Deposited As： | Pseudomonas pyrrocinia Imanaka et al. |
| Strain Designations： | 2327 CFBP 4794, CIP 105874, DSM 10685, LMG 14191 |
| Application： | Produces pyrrolnitrin |
| Isolation： | Soil Isolation date: April, 1963 |
| Biosafety Level： | 1
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Product Format： | freeze-dried |
| Storage Conditions： | 2°C to 8°C |
| Disclosure： | This material is cited in a US or other Patent and may not be used to infringe the claims. Depending on the wishes of the Depositor, ATCC may be required to inform the Patent Depositor of the party to which the material was furnished. This material may not have been produced or characterized by ATCC. |
| Preceptrol®： | no |
| Type Strain： | yes
RefImanaka H, et al. . J. Antibiot. Ser. A 18: 205-206, 1965. , RefSkerman VB, et al. Approved lists of bacterial names. Int J Syst Bacteriol 30: 225-420, 1980. , RefVandamme P, et al. Occurrence of multiple genomovars of Burkholderia cepacia in cystic fibrosis patients and proposal of Burkholderia multivorans sp. nov.. Int. J. Syst. Bacteriol. 47: 1188-1200, 1997. PubMed: 9336927 |
| Medium： | ATCC® Medium 3: Nutrient agar or nutrient broth |
| Growth Conditions： | Temperature: 30.0°C Atmosphere: Aerobic |
| Name of Depositor： | Fujisawa Pharmaceutical Company, Ltd., H Imanaka |
| U.S. Patent Number： | |
| Special Collection： | ATCC |
| Year of Origin： | 1963 |
| References： | Arima K, et al. Production of 3-(2-nitro-3-chlorophenyl)-4-chloro-pyrrole. US Patent 3,597,325 dated Aug 3 1971 Arima K, et al. Antibiotic. US Patent 3,699,121 dated Oct 17 1972 Imanaka H, et al. . J. Antibiot. Ser. A 18: 205-206, 1965. Nishida M, et al. Pyrrolnitrin, a new antifungal antibiotic. Microbiological and toxicological observations. J. Antibiot. Ser. A 18: 211-219, 1965. Skerman VB, et al. Approved lists of bacterial names. Int J Syst Bacteriol 30: 225-420, 1980. Vandamme P, et al. Occurrence of multiple genomovars of Burkholderia cepacia in cystic fibrosis patients and proposal of Burkholderia multivorans sp. nov.. Int. J. Syst. Bacteriol. 47: 1188-1200, 1997. PubMed: 9336927 Imanaka H, et al. . J. Antibiot. Ser. A 18: 205-206, 1965. Skerman VB, et al. Approved lists of bacterial names. Int J Syst Bacteriol 30: 225-420, 1980. Vandamme P, et al. Occurrence of multiple genomovars of Burkholderia cepacia in cystic fibrosis patients and proposal of Burkholderia multivorans sp. nov.. Int. J. Syst. Bacteriol. 47: 1188-1200, 1997. PubMed: 9336927 |
| Cross References： | Nucleotide (GenBank) : M60743 P. pyorocivia chloroperoxidase gene, complete cds. Nucleotide (GenBank) : AB021369 Burkholderia pyrrocinia DNA for 16S rRNA, strain TS209813T. |
